NEW YORK (GenomeWeb News) - The Translational Genomics Research Institute’s TD2 drug-development arm has agreed to use product-lifecycle software from Mission3, the organizations said recently.
TD2 will use the company’s MissionFire and FastCrossing software to help manage its drug development process.
FastCrossing is a graphical, web-based tool used in application submissions, while MissionFire is used in document and project management.
Financial terms of the agreement were not released.